Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Phytother Res ; 22(4): 472-6, 2008 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-18386252

RESUMEN

Angelicae Gigantis Radix (AGR) is one of the most widely used herbal medications. AGR is the dried root of Angelica gigas Nakai (Umbelliferae), which is known as Korean angelica. This study investigated the effects of AGR on osteoclast formation using primary bone marrow cells. TNF-alpha treatment increased tartrate-resistant acid phosphatase (Trap) positive cells and Trap activity in bone marrow cells. However, AGR significantly decreased both TNF-alpha-induced Trap positive cells and Trap activity. RT-PCR analyses revealed that AGR decreased mRNA levels of Trap and matrix metalloproteinase-9 in TNF-alpha-treated bone marrow cells. In addition, AGR decreased TNF-alpha-induced activation of NF-kappaB. These results suggest that AGR has an inhibitory effect on the formation of osteoclasts and its effect is partially related to the NF-kappaB pathway.


Asunto(s)
Angelica/química , Osteoclastos/efectos de los fármacos , Extractos Vegetales/farmacología , Fosfatasa Ácida/genética , Animales , Células de la Médula Ósea/citología , Células de la Médula Ósea/efectos de los fármacos , Células de la Médula Ósea/metabolismo , Células Cultivadas , Ensayo de Inmunoadsorción Enzimática , Isoenzimas/genética , Masculino , Metaloproteinasa 9 de la Matriz/genética , Ratones , FN-kappa B/metabolismo , Osteoclastos/citología , Osteoclastos/metabolismo , Extractos Vegetales/química , ARN Mensajero/genética , ARN Mensajero/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Fosfatasa Ácida Tartratorresistente , Factor de Necrosis Tumoral alfa/farmacología
2.
Neurol Res ; 29 Suppl 1: S16-22, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-17359635

RESUMEN

BACKGROUND: Herbs have been used to treat stroke and coma patient in traditional Korean medicine (TKM). The novel decoction, Guhpoongchungsimhwan (GCH), was developed on the basis of clinical data and TKM theory. METHODS: We examined the neuroprotective effect of GCH on cerebral ischemia. The middle cerebral artery occlusion (MCAO) model was used to produce cerebral ischemia in Sprague-Dawley rats. Subjects were treated with GCH (50 or 200 mg/kg) or vehicle alone (controls) 0 and 2 hours after MCAO. The functional status was tested 24 hours after MCAO by neurological examination (clinical score) and by series of motor function tasks (foot placement and parallel bar crossing). RESULTS: The infarct volume was determined by 2,3,5-triphenyltetrazolium chloride staining 24 hours after surgery, and the expression of cyclooxygenase-2 was determined by immunohistochemistry. The clinical score of the GCH-treated group (200 mg/kg) was significantly lower than that of the control group (p<0.05), indicating fewer neurological deficits. The impairment of motor functions induced by MCAO was significantly reduced by the administration of GCH (p<0.05). The infarct volume was significantly smaller in the GCH-treated group (203.1 +/- 40.2 mm(3), p<0.05), as compared to the control group (377.8 +/- 32.6 mm(3)). The level of motor function in the GCH-treated group was associated with reduced infarct volume. In the analysis of immunohistochemistry, GCH treatment markedly inhibited the ischemia-induced expression of PTGS2 (prostaglandin-endoperoxidase synthase 2) or cyclooxygenase 2 (COX2), which plays an important role in ischemic neuronal cell death. CONCLUSION: The results showed that GCH reduced the infarct size and the functional deficits in MCAO rats.


Asunto(s)
Isquemia Encefálica/prevención & control , Medicina de Hierbas/métodos , Fármacos Neuroprotectores/uso terapéutico , Animales , Infarto Encefálico/etiología , Infarto Encefálico/prevención & control , Isquemia Encefálica/etiología , Isquemia Encefálica/metabolismo , Isquemia Encefálica/patología , Ciclooxigenasa 2/metabolismo , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Expresión Génica/efectos de los fármacos , Infarto de la Arteria Cerebral Media/complicaciones , Masculino , Actividad Motora/efectos de los fármacos , Actividad Motora/fisiología , Examen Neurológico/métodos , Desempeño Psicomotor/efectos de los fármacos , Ratas , Ratas Sprague-Dawley , Factores de Tiempo
3.
J Ethnopharmacol ; 98(1-2): 157-62, 2005 Apr 08.
Artículo en Inglés | MEDLINE | ID: mdl-15763377

RESUMEN

Shiquandabutangjiaweibang (SDJ) is a traditional medicine prescription used for increasing body resistance against cancer. In the present study, the effect of SDJ extract on tumor metastasis and angiogenesis was evaluated. SDJ showed cytotoxicity against P388 (leukemia cells) and B16-F10 (murine melanoma cells) to 60% of control at 1 mg. SDJ significantly inhibited lung metastasis and also restored the number of platelets in C57BL/6 mice with thrombocytopenia induced by intravenous injection of B16-F10 cells. SDJ significantly disrupted chick embryonic angiogenesis in the chorioallantoic membrane (CAM). Interestingly, SDJ suppressed DNA topoisomerase I in a concentration-dependent manner. These results suggest that SDJ can be a potent inhibitor of metastasis and angiogenesis, at least in part, via regulation of topoisomerase I.


Asunto(s)
ADN-Topoisomerasas de Tipo I/efectos de los fármacos , ADN-Topoisomerasas de Tipo I/metabolismo , Metástasis de la Neoplasia/prevención & control , Neovascularización Patológica/prevención & control , Preparaciones de Plantas/farmacología , Animales , Supervivencia Celular/efectos de los fármacos , Membrana Corioalantoides/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Ensayos de Selección de Medicamentos Antitumorales/métodos , Humanos , Leucemia P388/patología , Leucemia P388/prevención & control , Neoplasias Pulmonares/prevención & control , Neoplasias Pulmonares/secundario , Masculino , Medicina Tradicional de Asia Oriental , Ratones , Ratones Endogámicos C57BL , Trasplante de Neoplasias/métodos , Neoplasias Experimentales/tratamiento farmacológico , Células Neoplásicas Circulantes/patología , Preparaciones de Plantas/análisis , Preparaciones de Plantas/química , Coloración y Etiquetado , Trombocitopenia/inducido químicamente , Trombocitosis/inducido químicamente , Células Tumorales Cultivadas
4.
Nutr Cancer ; 51(1): 78-82, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-15749633

RESUMEN

Citrus fruits have been known to reduce the proliferation of many cancer cells. The antiproliferative effects of Citrus reticulata Blanco (CR) extract, the immature tangerine peel, on human gastric cancer cell line SNU-668 were evaluated using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay, 4,6-diamidineo-2-phenylindole staining, terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling assay, reverse transcription-polymerase chain reaction expressions of BCL-2, BAX and CASP-3 genes, caspase-3 activity, and immunocytochemistry of caspase-3. From the results of the morphological and biochemical assays, CR (50 microg/ml) increased the apoptosis of human gastric cancer cells with typical apoptotic characteristics, including morphological changes of chromatin condensation and apoptotic body formation. CR (50 microg/ml) reduced the expression of BCL-2, whereas the expression of BAX and CASP-3 was increased compared with the control group. Furthermore, caspase-3 activity and caspase-3 protein expression in the CR-treated group was significantly increased compared with that in control group. These results suggest that CR may induce the apoptosis through the caspase-3 pathway in human gastric cancer cells.


Asunto(s)
Antineoplásicos/farmacología , Apoptosis/efectos de los fármacos , Citrus/química , Fitoterapia , Extractos Vegetales/farmacología , Neoplasias Gástricas/tratamiento farmacológico , Antineoplásicos/uso terapéutico , Caspasa 3 , Caspasas/efectos de los fármacos , Caspasas/metabolismo , Activación Enzimática/efectos de los fármacos , Genes bcl-2/efectos de los fármacos , Humanos , Inmunohistoquímica/métodos , Etiquetado Corte-Fin in Situ/métodos , Extractos Vegetales/uso terapéutico , Proteínas Proto-Oncogénicas c-bcl-2/efectos de los fármacos , Proteínas Proto-Oncogénicas c-bcl-2/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa/métodos , Neoplasias Gástricas/enzimología , Células Tumorales Cultivadas , Proteína X Asociada a bcl-2
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA